Showing results (221-230 of 254) with videos related to
Sort By:
Pageof 26
The Journal of Steroid Biochemistry and Molecular Biology|January 4, 2011
17β-Hydroxysteroid dehydrogenases (17β-HSDs) as therapeutic targets: protein structures, functions, and recent progress in inhibitor developmentSandrine Marchais-Oberwinkler, Claudia Henn, Gabriele Möller, et al.Bioorganic & Medicinal Chemistry|October 22, 2013
Trisubstituted and tetrasubstituted pyrazolines as a novel class of cell-growth inhibitors in tumor cells with wild type p53Mohammad Abdel-Halim, Adam B Keeton, Evrim Gurpinar, et al.Journal of Medicinal Chemistry|September 26, 2019
Anti-biofilm Agents against Pseudomonas aeruginosa: A Structure-Activity Relationship Study of C-Glycosidic LecB InhibitorsRoman Sommer, Katharina Rox, Stefanie Wagner, et al.Archiv Der Pharmazie|August 23, 2008
CYP17 inhibitors. Annulations of additional rings in methylene imidazole substituted biphenyls: synthesis, biological evaluation and molecular modellingMariano A E Pinto-Bazurco Mendieta, Matthias Negri, Qingzhong Hu, et al.Hypertension (Dallas, Tex. : 1979)|August 31, 2006
Aging reduces the efficacy of estrogen substitution to attenuate cardiac hypertrophy in female spontaneously hypertensive ratsVirginija Jazbutyte, Kai Hu, Patricia Kruchten, et al.Journal of Medicinal Chemistry|January 29, 2019
2-Aminothiazole Derivatives as Selective Allosteric Modulators of the Protein Kinase CK2. 1. Identification of an Allosteric Binding SiteBenoît Bestgen, Isabelle Krimm, Irina Kufareva, et al.Scientific Reports|October 6, 2020
Micro-rheological properties of lung homogenates correlate with infection severity in a mouse model of Pseudomonas aeruginosa lung infectionXabier Murgia, Andreas M Kany, Christian Herr, et al.Chemmedchem|August 18, 2017
Biophysical Screening of a Focused Library for the Discovery of CYP121 Inhibitors as Novel AntimycobacterialsChristian Brengel, Andreas Thomann, Alexander Schifrin, et al.Bioorganic Chemistry|November 4, 2020
Discovery of trisubstituted pyrazolines as a novel scaffold for the development of selective phosphodiesterase 5 inhibitorsMohammad Abdel-Halim, Heather Tinsley, Adam B Keeton, et al.Archiv Der Pharmazie|July 12, 2002
Inhibition of CYP 17, a new strategy for the treatment of prostate cancerRolf W Hartmann, Peter B Ehmer, Samer Haidar, et al.Pageof 26